IM Cannabis (US:IMCC) Prnewswire·2025-10-29 20:01Core Points - IM Cannabis Corp. announced the resignation of Chief Financial Officer Uri Birenberg for personal reasons, effective January 5, 2026, or earlier if determined by the company [1] - The CEO of IM Cannabis expressed gratitude for Birenberg's contributions over the past two years and wished him success in his future endeavors [2] - Birenberg stated his pleasure in serving as CFO and expressed confidence in the company's future [2] Company Overview - IM Cannabis Corp. is an international medical cannabis company operating in Israel and Germany, focusing on providing premium cannabis products to medical patients [3] - The company utilizes a data-driven approach and a globally sourced product supply chain to enhance its commercial and brand power [3] - IM Cannabis operates through subsidiaries in Israel, importing and distributing cannabis, and also runs medical cannabis retail pharmacies and distribution centers [4] - In Germany, the company distributes cannabis to pharmacies through its subsidiary Adjupharm GmbH [4]